4.7 Article

Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer

期刊

CANCER LETTERS
卷 359, 期 2, 页码 325-334

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2015.01.034

关键词

gp96; Apoptosis; Ubiquitination; Chaperone

类别

资金

  1. Major State Basic Research Development Program of China (973 Program) [2014CB542602, 2012CB519003]
  2. National Natural Science Foundation of China [31230026, 81321063, 81102018, 81471960]
  3. Key Projects in the National Science & Technology Program [2013ZX10002001-003-003, 2012ZX10004503]

向作者/读者索取更多资源

The resistance to apoptosis displayed by liver cancer plays a key role in hepatocarcinogenesis, tumor progression, and resistance to chemo- or radio-therapy. In this study, we uncovered the potential role and mechanism of heat shock protein gp96 in regulating liver tumor cell growth and apoptosis. P53 protein was identified as a gp96 client protein by profiling apoptosis-related proteins in gp96-knockdown liver cancer cells. Overexpression and knockdown studies both demonstrated that gp96 decreases p53 protein levels, and gp96 regulated cell apoptosis in a p53-dependent manner. We further provide evidence that gp96 interacts with both p53 and Mdm2 to enhance Mdm2-mediated p53 ubiquitination and degradation. Moreover, targeting gp96 with siRNA induced cell apoptosis and led to the suppression of liver tumor growth in vivo. In conclusion, we elucidated an underlying mechanism by which gp96 promotes p53 degradation via increasing Mdm2 E3 ligase activity and provided a new therapeutic strategy to target the gp96-mediated anti-apoptotic characteristic of hepatocellular carcinoma. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Chaperone gp96 mediates ER-α36 cell membrane expression

Junwei Hou, Mengmeng Deng, Xin Li, Weiwei Liu, Xiaoyu Chu, Jing Wang, Feng Chen, Songdong Meng

ONCOTARGET (2015)

Article Multidisciplinary Sciences

A cross-talk between Hepatitis B virus and host mRNAs confers viral adaptation to liver

Jun Hu, Yaxing Xu, Changfei Li, Junli Hao, Shanxin Peng, Xiaoyu Chu, Dake Zhang, Dongping Xu, Songdong Meng

SCIENTIFIC REPORTS (2015)

Article Pharmacology & Pharmacy

PTD-fused p53 as a potential antiviral agent directly suppresses HBV transcription and expression

Xiaoyu Chu, Bo Wu, Hongxia Fan, Junwei Hou, Junli Hao, Jun Hu, Baozhong Wang, Guangze Liu, Changfei Li, Songdong Meng

ANTIVIRAL RESEARCH (2016)

Article Virology

HDM2 Promotes NEDDylation of Hepatitis B Virus HBx To Enhance Its Stability and Function

Ningning Liu, Jinfang Zhang, Xiaohai Yang, Tong Jiao, Xin Zhao, Wenxia Li, Jianhua Zhu, Pu Yang, Jianping Jin, Jirun Peng, Zhiwei Li, Xin Ye

JOURNAL OF VIROLOGY (2017)

Article Gastroenterology & Hepatology

Hepatitis B Virus-Upregulated LNC-HUR1 Promotes Cell Proliferation and Tumorigenesis by Blocking p53 Activity

Ningning Liu, Qi Liu, Xiaohai Yang, Fang Zhang, Xinda Li, Yuanwu Ma, Feifei Guan, Xin Zhao, Zhiwei Li, Lianfeng Zhang, Xin Ye

HEPATOLOGY (2018)

Article Virology

Hepatitis B Virus Regulates Apoptosis and Tumorigenesis through the MicroRNA-15a-Smad7-Transforming Growth Factor Beta Pathway

Ningning Liu, Tong Jiao, Yan Huang, Wenjun Liu, Zhiwei Li, Xin Ye

JOURNAL OF VIROLOGY (2015)

Article Multidisciplinary Sciences

MYH9 is an Essential Factor for Porcine Reproductive and Respiratory Syndrome Virus Infection

Jiming Gao, Shuqi Xiao, Yihong Xiao, Xiangpeng Wang, Chong Zhang, Qin Zhao, Yuchen Nan, Baicheng Huang, Hongliang Liu, Ningning Liu, Junhua Lv, Taofeng Du, Yani Sun, Yang Mu, Gang Wang, Shahid Faraz Syed, Gaiping Zhang, Julian A. Hiscox, Ian Goodfellow, En-Min Zhou

SCIENTIFIC REPORTS (2016)

Article Multidisciplinary Sciences

LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1

Qi Liu, Ningning Liu, Qilin Shangguan, Fang Zhang, Wenjia Chai, Xiaomei Tong, Xin Zhao, Zhiwei Li, Dandan Qi, Xin Ye

SCIENTIFIC REPORTS (2019)

Article Gastroenterology & Hepatology

MicroRNA-15a/16-1 Prevents Hepatocellular Carcinoma by Disrupting the Communication Between Kupffer Cells and Regulatory T Cells

Ningning Liu, Ching Wen Chang, Clifford J. Steer, Xin Wei Wang, Guisheng Song

Summary: The study reveals that microRNA-15a/16-1 attenuates immunosuppression in hepatocellular carcinoma by disrupting CCL22-mediated communication between KCs and Tregs. MicroRNA-15a/16-1 represents a potential immunotherapy against HCC.

GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

MicroRNA-206 promotes the recruitment of CD8+ T cells by driving M1 polarisation of Kupffer cells

Ningning Liu, Xiaomei Wang, Clifford John Steer, Guisheng Song

Summary: The study revealed that M2 polarisation of Kupffer cells is a major contributor to hepatocellular carcinoma in AKT/Ras mice, while microRNA-206 prevents HCC by promoting M1 polarisation of Kupffer cells and enhancing recruitment of CD8(+) T cells, suggesting its potential use as an immunotherapeutic approach.
Article Gastroenterology & Hepatology

MicroRNA-206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c-Myc mice

Ningning Liu, Clifford J. Steer, Guisheng Song

Summary: This study revealed that c-Myc-educated hepatocytes promote immunosuppression by overproducing TGF beta 1, while miR-206 attenuates TGF beta 1 overproduction, disrupting the communication between malignant hepatocytes and CTLs/Tregs, thus preventing HCC development. miR-206 represents a potential immunotherapeutic agent against HCC.

HEPATOLOGY (2022)

Article Biochemistry & Molecular Biology

MicroRNA-378a-3p prevents initiation and growth of colorectal cancer by fine tuning polyamine synthesis

Ningning Liu, Tianpeng Zhang, Clifford J. Steer, Guisheng Song

Summary: miR-378a prevents colorectal cancer by inhibiting polyamine synthesis, suggesting its potential as a therapeutic agent against CRC.

CELL AND BIOSCIENCE (2022)

Article Medicine, Research & Experimental

Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis

Tianpeng Zhang, Hongtao Shi, Ningning Liu, Jing Tian, Xiaoling Zhao, Clifford J. Steer, Qinghua Han, Guisheng Song

THERANOSTICS (2020)

Review Oncology

Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy

Xinru Zhou, Yin Jia, Chuanbin Mao, Shanrong Liu

Summary: Small extracellular vesicles (sEVs), such as exosomes, have emerged as crucial targets for liquid biopsy and promising drug delivery vehicles in tumor progression. They can serve as biomarkers for tumor diagnosis and as drug carriers for cancer treatment.

CANCER LETTERS (2024)

Article Oncology

HMGB1 in the interplay between autophagy and apoptosis in cancer

Ruochan Chen, Ju Zhu, Xiao Zhong, Jie Li, Rui Kang, Daolin Tang

Summary: The interplay between autophagy and apoptosis plays a crucial role in tumorigenesis and cancer therapy, with HMGB1 serving as a key regulator in these processes.

CANCER LETTERS (2024)

Article Oncology

Epigenetic inhibition of CTCF by HN1 promotes dedifferentiation and stemness of anaplastic thyroid cancer

Zongfu Pan, Xixuan Lu, Tong Xu, Jinming Chen, Lisha Bao, Ying Li, Yingying Gong, Yulu Che, Xiaozhou Zou, Zhuo Tan, Ping Huang, Minghua Ge

Summary: This study uncovered the emerging role of HN1 in promoting dedifferentiation of anaplastic thyroid cancer (ATC) cells. HN1 negatively regulated the thyroid differentiation markers and had an inhibitory effect on the transcriptional activation of CTCF, thereby influencing the chromatin accessibility of thyroid differentiation genes.

CANCER LETTERS (2024)

Article Oncology

Autophagy machinery in glioblastoma: The prospect of cell death crosstalk and drug resistance with bioinformatics analysis

Yi Qin, Shengjun Xiong, Jun Ren, Gautam Sethi

Summary: Autophagy plays an important regulatory role in glioblastoma, and its dysregulation can lead to drug resistance and radioresistance. It also affects stem cell characteristics, overall growth, and metastasis. Therefore, autophagy is a promising target for glioblastoma therapy.

CANCER LETTERS (2024)

Article Oncology

Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase

Katsuya Nagaoka, Xuewei Bai, Dan Liu, Kevin Cao, Joud Mulla, Chengcheng Ji, Hongze Chen, Muhammad Azhar Nisar, Amalia Bay, William Mueller, Grace Hildebrand, Jin-Song Gao, Shaolei Lu, Hiroko Setoyama, Yasuhito Tanaka, Jack R. Wands, Chiung-Kuei Huang

Summary: This study found that serum 2-OG levels in cholangiocarcinoma patients are associated with the effectiveness of chemotherapy. Patients with progressive disease showed significantly higher levels of serum 2-OG compared to stable disease and partial response patients. The study also revealed that overexpression of ASPH mimics the effects of 2-OG, and knockdown of ASPH improves chemotherapy. Targeting ASPH enhances the effects of chemotherapy by modulating ATM and ATR, two key regulators of DDRs.

CANCER LETTERS (2024)